Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Go to hell

<< Previous

Bullboard Posts

Next >>

Comment by longterm56on Jul 11, 2022 4:23pm

81 Views

Post# 34816215

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Go to hell

2 years? Kind of an exaggeration. -LT

canadapiet wrote: The fact that after 2 years of trials there is still no sign of a real "effect" on the tumors should tell you something. At best, there may be a sign but it will for sure not be "earthshattering"!
So the necessary capital increase is hanging over the actual shareprice!
How can a CEO tell the community they are in "a very strong position"???!!!!
They need in the very short time a lot of money if they will continue the more costing new trials!! (and there is also the convertible.....)
But maybe, perhaps, they can convince a Chinese B Pharma .........??

GLA